• 1. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 2. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 3. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 4. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 5. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazinanes Piperazines

Introduction to 1-(cyclopropanesulfonyl)piperazine (CAS No. 1043529-57-2)

1-(cyclopropanesulfonyl)piperazine, identified by its Chemical Abstracts Service (CAS) number 1043529-57-2, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the piperazine class, characterized by its six-membered heterocyclic structure containing two nitrogen atoms. The presence of a cyclopropane sulfonyl group at the para position of the piperazine ring imparts unique chemical and pharmacological properties, making it a valuable scaffold for drug discovery and development.

The structural motif of 1-(cyclopropanesulfonyl)piperazine has been extensively explored for its potential in modulating various biological targets. Piperazine derivatives are well-known for their versatility in pharmaceutical applications, often serving as key intermediates in the synthesis of bioactive molecules. The cyclopropane sulfonyl moiety, in particular, has been associated with enhanced binding affinity and metabolic stability, which are critical factors in the design of novel therapeutic agents.

In recent years, 1-(cyclopropanesulfonyl)piperazine has been investigated for its role in the development of drugs targeting neurological and inflammatory disorders. Its ability to interact with specific receptors and enzymes has positioned it as a promising candidate for further pharmacological exploration. For instance, studies have suggested that this compound may exhibit inhibitory effects on certain kinases and phosphodiesterases, which are implicated in various pathological conditions.

One of the most compelling aspects of 1-(cyclopropanesulfonyl)piperazine is its synthetic accessibility. The compound can be readily prepared through well-established organic reactions, such as sulfonylation of piperazine derivatives using cyclopropane sulfonyl chloride. This synthetic route not only ensures high yield but also allows for modifications at other positions on the piperazine ring, enabling the generation of a diverse library of analogs for structure-activity relationship (SAR) studies.

The pharmacokinetic profile of 1-(cyclopropanesulfonyl)piperazine has also been a subject of interest. Preliminary studies indicate that this compound exhibits moderate solubility in both water and organic solvents, which is advantageous for formulating it into various pharmaceutical dosage forms. Additionally, its stability under different storage conditions suggests potential for long-term stability, which is crucial for commercial drug development.

Recent advancements in computational chemistry have further enhanced the understanding of 1-(cyclopropanesulfonyl)piperazine's interactions with biological targets. Molecular docking simulations have revealed that this compound can bind to specific pockets on proteins with high affinity, suggesting its potential as a lead compound for drug design. These computational approaches have complemented experimental efforts, providing insights into the binding mechanisms and optimizing lead compounds for further development.

The therapeutic potential of 1-(cyclopropanesulfonyl)piperazine extends beyond neurological disorders. Emerging research suggests that this compound may have applications in treating inflammatory conditions by modulating immune responses. The cyclopropane sulfonyl group has been shown to interfere with pro-inflammatory signaling pathways, making it a candidate for developing anti-inflammatory agents.

In conclusion, 1-(cyclopropanesulfonyl)piperazine (CAS No. 1043529-57-2) represents a fascinating compound with multifaceted applications in pharmaceutical research. Its unique structural features, synthetic tractability, and promising pharmacological properties make it an attractive scaffold for developing novel therapeutic agents. As research continues to uncover new biological targets and mechanisms, the potential uses of this compound are likely to expand further, contributing to advancements in drug discovery and medicinal chemistry.

• 534615-34-4(1-(Isopropylsulfonyl)piperazine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)